SCHEMBL11083042

SCHEMBL11083042

C[S+]([O-])c1ccc(-c2[nH]c(C(N)(C(F)(F)F)C(F)(F)F)nc2-c2ccc(F)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 1/20 0.49
PTGS1 P23219 4/20 0.40
PTGS2 P35354 4/20 0.40
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
MAPK14 Q16539 9/20 0.39
MAPK11 Q15759 8/20 0.39
MAPK13 O15264 7/20 0.39
MAPK12 P53778 7/20 0.39
GCGR P47871 6/20 0.39
CSNK1A1 P48729 2/20 0.39
CSNK1D P48730 2/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39
FRK P42685 1/20 0.39
MAPK9 P45984 1/20 0.39
GSK3B P49841 1/20 0.39
PTK6 Q13882 1/20 0.39
PRKD2 Q9BZL6 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11082923 0.87 BRAF (0.57) BRAFPTGS1PTGS2ESR1ESR2
SCHEMBL7488369 0.81 PTGS2 (0.64) BRAFPTGS1PTGS2MAPK14MAPK11
SCHEMBL11087266 0.81 PTGS2 (0.64) BRAFPTGS1PTGS2MAPK14MAPK11
SCHEMBL11092755 0.81 MAPK14 (0.56) BRAFESR1ESR2MAPK14MAPK11
SCHEMBL11087416 0.81 MAPK14 (0.56) BRAFPTGS1PTGS2ESR1ESR2
SCHEMBL11087907 0.78 ESR1 (0.47) BRAFESR1ESR2MAPK14MAPK11
SCHEMBL11087423 0.75 BRAF (0.45) BRAFESR1ESR2MAPK14MAPK11
SCHEMBL11087790 0.75 NOX1 (0.50) BRAFESR1ESR2MAPK14MAPK11
SCHEMBL9192799 0.73 MAPK11 (0.75) BRAFPTGS1MAPK14MAPK11MAPK13
Sb-203580 SCHEMBL146399 0.73 MAPK11 (0.75) BRAFPTGS1MAPK14MAPK11MAPK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4472422-A Antihypertensive 4,5-diaryl-α-polyfluoro-alkyl-1H-imidazole-2-methanamines E. I. DU PONT DE NEMOURS AND COMPANY (US) 1984-09-18 US disclosed
EP-0023594-B1 TRANS-QUINAZOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, INTERMEDIATES AND MEDICAMENTS CONTAINING THESE DERIVATIVES F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1984-05-16 EP disclosed